Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Trial Comparing Mini-Arc Precise Pro and the Trans Vaginal Obturator Tape for Stress Urinary Incontinence

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified January 2016 by University of Manitoba
Information provided by (Responsible Party):
Ken Maslow, University of Manitoba Identifier:
First received: February 22, 2013
Last updated: January 8, 2016
Last verified: January 2016
Randomized comparison of two surgeries for the treatment of female stress urinary incontinence.

Condition Intervention Phase
Stress Urinary Incontinence
Urethral Sling Surgery
Device: Mini Arc Precise Pro and Trans vaginal obturator sling (TVT-0)
Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Randomized Clinical Trial Comparing Mini-Arc Precise Pro and the Trans Vaginal Obturator Tape for Surgical Management of Stress Urinary Incontinence

Resource links provided by NLM:

Further study details as provided by University of Manitoba:

Primary Outcome Measures:
  • Cough test at one year from surgery [ Time Frame: One year ]

Secondary Outcome Measures:
  • Subjective symptoms, QOL questionaires [ Time Frame: 1 & 2 years post surgery ]

Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Precise sling vs TVT-O sling Device: Mini Arc Precise Pro and Trans vaginal obturator sling (TVT-0)


Ages Eligible for Study:   25 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • women with stress urinary incontinence with a positive cough test
  • patient request surgery for treatment

Exclusion Criteria:

  • prodominantely overactive bladder
  • previous failed procedure
  • MUCP <20 cm H2O
  • presence of vaginal prolapse > stage 1
  • voiding dysfunction (PVR>100 mL)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01799122

Canada, Manitoba
Ken Maslow Not yet recruiting
Winnipeg, Manitoba, Canada, R2H 2A6
Contact: Ken D Maslow, MD    204-235-3039   
Sponsors and Collaborators
University of Manitoba
  More Information

Responsible Party: Ken Maslow, Assistent Professor, University of Manitoba Identifier: NCT01799122     History of Changes
Other Study ID Numbers: B2012:047
Study First Received: February 22, 2013
Last Updated: January 8, 2016

Additional relevant MeSH terms:
Urinary Incontinence
Urinary Incontinence, Stress
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms
Behavioral Symptoms
Elimination Disorders
Mental Disorders processed this record on May 23, 2017